Ad is loading...
MENU

CNCR Stock Tickeron detected bearish ETF Pattern: Head-and-Shoulders Top CNCR on November 13, 2024, netting in a 5.99% gain over 1 week

A.I.dvisor
at Tickeron.com
Loading...
+5.99% Gain from a Successful pattern Head-and-Shoulders Top
CNCR - Range Cancer Therapeutics ETF
Tickeron
Ticker: CNCR
Company: Range Cancer Therapeutics ETF
Gain from shortening: +5.99%
Confirmed: 11/13/24
Succeeded: 11/14/24
Total length: 9 days
On November 05, 2024, A.I.dvisor detected a Head-and-Shoulders Top Pattern (Bearish) for Range Cancer Therapeutics ETF (CNCR, $15.16). 8 days later, on November 13, 2024, A.I.dvisor confirmed the Bearish pattern, setting a target price of the stock. On November 14, 2024, the stock hit the target price of $13.55 – resulting in a gain for traders who shorted the stock on the pattern detection date.

CNCR in -1.56% downward trend, sliding for three consecutive days on November 21, 2024

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CNCR declined for three days, in of 301 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 13, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on CNCR as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CNCR turned negative on November 14, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 56 similar instances when the indicator turned negative. In of the 56 cases the stock turned lower in the days that followed. This puts the odds of success at .

CNCR moved below its 50-day moving average on November 13, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CNCR crossed bearishly below the 50-day moving average on November 15, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CNCR's RSI Oscillator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CNCR advanced for three days, in of 284 cases, the price rose further within the following month. The odds of a continued upward trend are .

CNCR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 197 cases where CNCR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

View a ticker or compare two or three
CNCR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
ETF Series Solutions615 East Michigan Street, Milwaukee, WisconsinEast Michigan
Phone
(414) 765-5586
Web
N/A